Last reviewed · How we verify
Intravenous lidocaine administration
At a glance
| Generic name | Intravenous lidocaine administration |
|---|---|
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Nausea
- Vomiting
- Dizziness
- Severe pain
- Shingles
- Procedure site swelling
- Respiratory Depression
- Tachycardia
- Diaphoresis
- Dural Puncture
Key clinical trials
- Sphenopalatine Ganglion Block for Post-Dural Puncture Headache: A Pilot Randomised Controlled Trial (NA)
- Effect of Erector Spinae Plane Block on Postoperative Analgesia and Stress Response in Laparoscopic Sleeve Gastrectomy (NA)
- Evaluation of Response to Pain From Skull Pin Fixation in Craniotomies
- Comparison of Systemic Opioid (Morphine) and Pre-Incision Bilateral Scalp Nerve Block for Pain Management in Craniotomy Patients (PHASE4)
- The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain. (EARLY_PHASE1)
- Supraclavicular Block vs Bier's Block for Forearm Trauma Surgery (NA)
- Intravenous Lidocaine in Bariatric Surgery. (PHASE3)
- Intravenous Lidocaine Plus Port-Site Ropivacaine for Recovery After Laparoscopic Surgery (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: